Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAL0137 in Elevated Lipoprotein(a)
NCT07729475Phase 2Not yet recruiting
- Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Start
- Jul 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
A Phase 2 trial of SAL0137 in elevated lipoprotein(a) (Lp(a)), sponsored by Shenzhen Salubris Pharmaceuticals Co., Ltd.. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
SAL0137
03
Conditions
elevated lipoprotein(a) (Lp(a))
Beyond the preview
Go deeper on NCT07729475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07729475.